COSMOS HEALTH INC. Proceeds from Sale of Treasury Stock
COSMOS HEALTH INC. (COSM) reported Proceeds from Sale of Treasury Stock of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfTreasuryStock · last filed 2023-04-12
- COSMOS HEALTH INC. proceeds from sale of treasury stock for the quarter ending 2020-12-31 was -$120.00K.
- COSMOS HEALTH INC. proceeds from sale of treasury stock for the quarter ending 2020-09-30 was -$80.00K.
- COSMOS HEALTH INC. proceeds from sale of treasury stock for the quarter ending 2019-12-31 was $0.00.
- COSMOS HEALTH INC. proceeds from sale of treasury stock for the quarter ending 2019-09-30 was -$57.12K.
- COSMOS HEALTH INC. proceeds from sale of treasury stock for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- COSMOS HEALTH INC. proceeds from sale of treasury stock for fiscal 2021 was $250.00K.
- COSMOS HEALTH INC. proceeds from sale of treasury stock for fiscal 2020 was -$200.00K.
- COSMOS HEALTH INC. proceeds from sale of treasury stock for fiscal 2019 was -$845.25K.
| Period end | Proceeds from Sale of Treasury Stock 3 month | Proceeds from Sale of Treasury Stock 6 month | Proceeds from Sale of Treasury Stock 9 month | Proceeds from Sale of Treasury Stock 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-04-12 | |||
| 2021-12-31 | $250.00K 10-K · filed 2023-04-12 | |||
| 2020-12-31 | -$120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | -$200.00K derived: sum of 2 quarters · filed 2021-04-15 | -$200.00K 10-K · filed 2021-04-15 | |
| 2020-09-30 | -$80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$80.00K 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-13 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | -$57.12K derived: sum of 2 quarters · filed 2021-04-15 | -$773.71K derived: sum of 3 quarters · filed 2021-04-15 | -$845.25K 10-K · filed 2021-04-15 |
| 2019-09-30 | -$57.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$773.71K derived: sum of 2 quarters · filed 2020-11-16 | -$845.25K 10-Q · filed 2020-11-16 | -$878.81K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$716.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$788.13K 10-Q · filed 2020-08-13 | -$821.69K derived: sum of 3 quarters · filed 2020-08-13 | |
| 2019-03-31 | -$71.54K 10-Q · filed 2020-05-15 | -$105.11K derived: sum of 2 quarters · filed 2020-05-15 | ||
| 2018-12-31 | -$33.56K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-14 | -$80.05K 10-K · filed 2020-04-14 | ||
| 2018-09-30 | -$46.49K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |